Prostate Cancer

>

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Latest News

Carotuximab plus Erleada proved safe in a metastatic castration-resistant prostate cancer phase 2 trial: © stock.adobe.com.
Carotuximab Combo Proves Safe for Advanced Prostate Cancer

July 16th 2025

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on the phase 2 trial.

Image of man with text.
Identifying Patients Who Will Benefit From Intensified Prostate Cancer Treatment

July 12th 2025

The FDA granted FTD to TRE-515 & radioligand therapy for PSMA+ mCRPC: © stock.adobe.com.
Fast Track Status Granted by FDA to TRE-515 in Prostate Cancer

July 11th 2025

Image of prostate
Long-Term Outcomes Support NCCN Guidelines for Prostate Cancer

July 10th 2025

Image of doctor with text.
Erleada May Be a New Standard of Care for Some With Prostate Cancer

July 10th 2025

Educated Patient Resource Guide

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Resource guide for prostate cancer

More News